sb 203580 has been researched along with cholecystokinin in 2 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (cholecystokinin) | Trials (cholecystokinin) | Recent Studies (post-2010) (cholecystokinin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 10,914 | 466 | 1,074 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bragado, MJ; Ernst, SA; Groblewski, GE; Ross, SE; Schäfer, C; Williams, JA | 1 |
Gonzalez, A; Schmid, A; Schulz, I; Siegel, G; Sternfeld, L | 1 |
2 other study(ies) available for sb 203580 and cholecystokinin
Article | Year |
---|---|
A role for the p38 mitogen-activated protein kinase/Hsp 27 pathway in cholecystokinin-induced changes in the actin cytoskeleton in rat pancreatic acini.
Topics: Actins; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell-Free System; Cholecystokinin; Cytoskeleton; Enzyme Activation; Enzyme Inhibitors; Hypertonic Solutions; Imidazoles; Intracellular Signaling Peptides and Proteins; Kinetics; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pancreas; Phosphorylation; Phosphotyrosine; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Signal Transduction; Sincalide; Sorbitol | 1998 |
Arachidonic acid modulates the spatiotemporal characteristics of agonist-evoked Ca2+ waves in mouse pancreatic acinar cells.
Topics: Acetylcholine; Animals; Arachidonic Acid; Arachidonic Acids; Bombesin; Calcium Signaling; Cells, Cultured; Cholecystokinin; Enzyme Inhibitors; Flavonoids; Imidazoles; Indomethacin; Kinetics; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Pancreas; Phosphorylation; Pyridines | 2001 |